TGFB1 antibody (AA 281-390) (FITC)

Catalog No. ABIN7172816

This Rabbit Polyclonal antibody specifically detects TGFB1 . It exhibits reactivity toward Human.

Quick Overview for TGFB1 antibody (AA 281-390) (FITC) (ABIN7172816)

Target: TGFB1 (Transforming Growth Factor, beta 1 (TGFB1))

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This TGFB1 antibody is conjugated to FITC

Application: Please inquire

Product Details anti-TGFB1 Antibody (FITC)

Binding Specificity: AA 281-390

Purpose: TGFB1 Antibody, FITC conjugated

Purification: Protein G purified

Purity: >95 %

Immunogen: Recombinant Human Transforming growth factor beta-1 proprotein protein (281-390AA)

Isotype: IgG

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4

Preservative: ProClin

Precaution of Use: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: -20 °C,-80 °C

Storage Comment: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Target Details for TGFB1

Target: TGFB1 (Transforming Growth Factor, beta 1 (TGFB1))

Alternative Name: TGFB1

Background: Cartilage-inducing factor antibody, CED antibody, Differentiation inhibiting factor antibody, DPD1 antibody, LAP antibody, Latency-associated peptide antibody, Prepro transforming growth factor beta 1 antibody, TGF beta 1 antibody, TGF beta antibody, TGF beta 1 protein antibody, TGF-beta 1 protein antibody, TGF-beta-1 antibody, TGF-beta-5 antibody, TGF-beta1 antibody, TGFB antibody, Tgfb-1 antibody, tgfb1 antibody, TGFB1_HUMAN antibody, TGFbeta antibody, TGFbeta1 antibody, Transforming Growth Factor b1 antibody, Transforming Growth Factor beta 1 antibody, Transforming growth factor beta 1a antibody, transforming growth factor beta-1 antibody, transforming growth factor, beta 1 antibody, Transforming Growth Factor-1 antibody

UniProt: P01137

Pathways: EGFR Signaling Pathway, Dopaminergic Neurogenesis, Cellular Response to Molecule of Bacterial Origin, Glycosaminoglycan Metabolic Process, Regulation of Leukocyte Mediated Immunity, Regulation of Muscle Cell Differentiation, Positive Regulation of Immune Effector Process, Cell-Cell Junction Organization, Production of Molecular Mediator of Immune Response, Ribonucleoside Biosynthetic Process, Skeletal Muscle Fiber Development, Regulation of Carbohydrate Metabolic Process, Protein targeting to Nucleus, Autophagy, Cancer Immune Checkpoints